PTEN Heads Into Earnings With Bulls Firmly in Control
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Patterson-UTI Energy reports Q3 results on October 29 with options positioning near the most bullish extreme of the past year and a 12% price gain over the past month providing a tailwind into the print.
The clearest bullish signal is in options. The put/call ratio has dropped to 0.20, roughly 1.5 standard deviations below its 20-day average, and is closing in on its 52-week low of 0.10. That points to heavy demand for call exposure rather than downside protection. Short interest at 8.1% of the free float is meaningful but has been unwinding, falling more than 11% over the past month to around 30.7 million shares. Borrow conditions tell the same story: availability is exceptionally loose at 2,444%, meaning there are roughly 24 shares available to borrow for every one currently lent out, and borrowing costs have eased to 0.42%, down 13% on the week. The lending market is not generating any squeeze pressure here.
The bull and bear cases hinge almost entirely on where U.S. land drilling activity goes from here. Bulls point to management's raised Q2 2026 adjusted EBITDA guidance of approximately $220 million, an active U.S. rig count approaching 95 with a target of more than 100 by year-end, and frac pricing that is firming as supply tightens. The Completion Services fleet is roughly 80% capable of burning natural gas today, a commercial advantage as E&P operators prioritize fuel efficiency. Bears argue the company's margins are hostage to a macro recovery that may not materialize: in the downside scenario, rig counts, day rates, frac fleets, and revenue per day all fall together, producing 2027 EBITDA of only $0.84 billion, and E&P consolidation among customers could further erode pricing power. The Street's consensus is a cautious hold, with the average target at $13.93 against a current price of $12.25. UBS reinstated in early October at Neutral with a $13 target; Citigroup trimmed its target from $13.50 to $12.50 around the same time. Barclays and Stifel carry more constructive views, at Overweight and Buy respectively, with targets of $16 and $15.
One note on insider activity: five insiders sold open-market shares over August and September, including the CEO twice, with net insider disposals totaling approximately 1.03 million shares worth roughly $12.7 million over the past 90 days. Two of the CEO's sales were executed outside a 10b5-1 plan, which makes them more discretionary than pre-arranged. The selling occurred while the stock was trading in the $11.50 to $13 range, close to where it trades today, so the overhang is real even if the broader positioning looks constructive. Peers including HAL, HP, and NBR have all gained 4% to 5% on the day and 4% on the week, confirming the sector move is broad rather than name-specific.
Wednesday's print will test whether the activity upturn management described in its last guidance raise is translating into the margin expansion that would justify the stock's sharp recovery from its September lows.
Stocks in this article
See the live data behind this article on ORTEX.
Open PTEN on ORTEX →How this article was generated
- Generated
- 27 Oct 2026, 04:27
- Data as of
- 27 Oct 2026, 04:02
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.